{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:04:59Z","timestamp":1789733099783,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:00:00Z","timestamp":1705795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T00:00:00Z","timestamp":1705795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012774","name":"Innovationsfonden","doi-asserted-by":"publisher","award":["12-135225"],"award-info":[{"award-number":["12-135225"]}],"id":[{"id":"10.13039\/100012774","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Research Foundation for the Capital Region of Denmark"},{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","award":["11-04-R83-A3363-22625"],"award-info":[{"award-number":["11-04-R83-A3363-22625"]}],"id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aalborg University Talent Management Program"},{"name":"Arvid Nilssons Fond,Denmark"},{"name":"Skibsreder Per Henriksen, R. og hustrus fond,Denmark"},{"name":"The AFFECT-EU Consortium","award":["847770-AFFECT-EU"],"award-info":[{"award-number":["847770-AFFECT-EU"]}]},{"DOI":"10.13039\/501100008269","name":"L\u00e6ge Sophus Carl Emil Friis og hustru Olga Doris Friis' Legat","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medtronic"},{"name":"National Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Epicardial adipose tissue (EAT) has endocrine and paracrine functions and has been associated with metabolic and cardiovascular disease. This study aimed to investigate the association between EAT, determined by cardiac magnetic resonance imaging (CMR), and incident atrial fibrillation (AF) following long-term continuous heart rhythm monitoring by implantable loop recorder (ILR). This study is a sub-study of the LOOP study. In total, 203 participants without a history of AF received an ILR and underwent advanced CMR. All participants were at least 70\u00a0years of age at inclusion and had at least one of the following conditions: hypertension, diabetes, previous stroke, or heart failure. Volumetric measurements of atrial- and ventricular EAT were derived from CMR and the time to incident AF was subsequently determined. A total of 78 participants (38%) were diagnosed with subclinical AF during a median of 40 (37\u201342) months of continuous monitoring. In multivariable Cox regression analyses adjusted for age, sex, and various comorbidities, we found EAT indexed to body surface area to be independently associated with the time to AF with hazard ratios (95% confidence intervals) up to 2.93 (1.36\u20136.34); p\u2009=\u20090.01 when analyzing the risk of new-onset AF episodes lasting\u2009\u2265\u200924\u00a0h. Atrial EAT assessed by volumetric measurements on CMR images was significantly associated with the incident AF episodes as detected by ILR.<\/jats:p>","DOI":"10.1007\/s10554-023-03029-z","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T14:02:13Z","timestamp":1705845733000},"page":"591-599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Epicardial adipose tissue and subclinical incident atrial fibrillation as detected by continuous monitoring: a cardiac magnetic resonance imaging study"],"prefix":"10.1007","volume":"40","author":[{"given":"Eva","family":"Guldberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Z\u00f6ga","family":"Diederichsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketil J\u00f8rgen","family":"Haugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Brandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derk","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Salling","family":"Olesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"H\u00f8jberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Vejlstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litten","family":"Bertelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Hastrup","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,21]]},"reference":[{"key":"3029_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/FCVM.2021.658445","author":"MI Rosa","year":"2021","unstructured":"Rosa MI et al (2021) Association between epicardial adipose tissue and stroke. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/FCVM.2021.658445","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"3029_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22(8):983\u2013988. https:\/\/doi.org\/10.1161\/01.STR.22.8.983","journal-title":"Stroke"},{"issue":"5","key":"3029_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/EURHEARTJ\/EHAA612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the Europea. Eur Heart J 42(5):373\u2013498. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAA612","journal-title":"Eur Heart J"},{"issue":"14","key":"3029_CR4","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.117.028845","volume":"136","author":"JS Healey","year":"2017","unstructured":"Healey JS et al (2017) Subclinical atrial fibrillation in older patients. Circulation 136(14):1276\u20131283. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028845","journal-title":"Circulation"},{"issue":"10","key":"3029_CR5","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/J.AMJCARD.2019.08.009","volume":"124","author":"OM Aldaas","year":"2019","unstructured":"Aldaas OM et al (2019) Meta-analysis of effect of modest (\u226510%) weight loss in management of overweight and obese patients with atrial fibrillation. Am J Cardiol 124(10):1568\u20131574. https:\/\/doi.org\/10.1016\/J.AMJCARD.2019.08.009","journal-title":"Am J Cardiol"},{"issue":"8","key":"3029_CR6","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/EUROPACE\/EUAC015","volume":"24","author":"AL Poggi","year":"2022","unstructured":"Poggi AL, Gaborit B, Schindler TH, Liberale L, Montecucco F, Carbone F (2022) Epicardial fat and atrial fibrillation: the perils of atrial failure. Europace 24(8):1201\u20131212. https:\/\/doi.org\/10.1093\/EUROPACE\/EUAC015","journal-title":"Europace"},{"key":"3029_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13277","author":"M Couselo-Seijas","year":"2021","unstructured":"Couselo-Seijas M, Rodr\u00edguez-Ma\u00f1ero M, Gonz\u00e1lez-Juanatey JR, Eiras S (2021) Updates on epicardial adipose tissue mechanisms on atrial fibrillation. Obes Rev. https:\/\/doi.org\/10.1111\/obr.13277","journal-title":"Obes Rev"},{"key":"3029_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS10092501","author":"A Krishnan","year":"2021","unstructured":"Krishnan A et al (2021) Are interactions between epicardial adipose tissue, cardiac fibroblasts and cardiac myocytes instrumental in atrial fibrosis and atrial fibrillation? Cells. https:\/\/doi.org\/10.3390\/CELLS10092501","journal-title":"Cells"},{"issue":"12","key":"3029_CR9","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1113\/JP273049","volume":"595","author":"AS Antonopoulos","year":"2017","unstructured":"Antonopoulos AS, Antoniades C (2017) The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol 595(12):3907\u20133917. https:\/\/doi.org\/10.1113\/JP273049","journal-title":"J Physiol"},{"issue":"2","key":"3029_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/J.YJMCC.2008.05.006","volume":"45","author":"M Kim","year":"2008","unstructured":"Kim M et al (2008) Role of resistin in cardiac contractility and hypertrophy. J Mol Cell Cardiol 45(2):270\u2013280. https:\/\/doi.org\/10.1016\/J.YJMCC.2008.05.006","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"3029_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/CVR\/CVU045","volume":"102","author":"SN Hatem","year":"2014","unstructured":"Hatem SN, Sanders P (2014) Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res 102(2):205\u2013213. https:\/\/doi.org\/10.1093\/CVR\/CVU045","journal-title":"Cardiovasc Res"},{"key":"3029_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/EUROPACE\/EUAC015","author":"AL Poggi","year":"2022","unstructured":"Poggi AL, Gaborit BE, Schindler TH, Liberale L, Montecucco F, Carbone F (2022) Epicardial fat and atrial fibrillation: the perils of atrial failure. EP Eur. https:\/\/doi.org\/10.1093\/EUROPACE\/EUAC015","journal-title":"EP Eur"},{"issue":"6","key":"3029_CR13","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/J.AHJ.2007.03.019","volume":"153","author":"HS Sacks","year":"2007","unstructured":"Sacks HS, Fain JN (2007) Human epicardial adipose tissue: a review. Am Heart J 153(6):907\u2013917. https:\/\/doi.org\/10.1016\/J.AHJ.2007.03.019","journal-title":"Am Heart J"},{"issue":"10310","key":"3029_CR14","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","volume":"398","author":"JH Svendsen","year":"2021","unstructured":"Svendsen JH et al (2021) Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet 398(10310):1507\u20131516. https:\/\/doi.org\/10.1016\/S0140-6736(21)01698-6","journal-title":"Lancet"},{"issue":"8","key":"3029_CR15","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/J.JCMG.2020.03.024","volume":"13","author":"L Bertelsen","year":"2020","unstructured":"Bertelsen L et al (2020) Left atrial late gadolinium enhancement is associated with incident atrial fibrillation as detected by continuous monitoring with implantable loop recorders. JACC Cardiovasc Imaging 13(8):1690\u20131700. https:\/\/doi.org\/10.1016\/J.JCMG.2020.03.024","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"3029_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/EUROPACE\/EUAA035","volume":"22","author":"L Bertelsen","year":"2020","unstructured":"Bertelsen L et al (2020) Left atrial volume and function assessed by cardiac magnetic resonance imaging are markers of subclinical atrial fibrillation as detected by continuous monitoring. EP Eur 22(5):724\u2013731. https:\/\/doi.org\/10.1093\/EUROPACE\/EUAA035","journal-title":"EP Eur"},{"key":"3029_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.112.000102","author":"A Alonso","year":"2013","unstructured":"Alonso A et al (2013) Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Hear Assoc. https:\/\/doi.org\/10.1161\/JAHA.112.000102","journal-title":"J Am Hear Assoc"},{"key":"3029_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2303062","author":"P Kirchhof","year":"2023","unstructured":"Kirchhof P et al (2023) Anticoagulation with edoxaban in patients with atrial high-rate episodes. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMOA2303062","journal-title":"N Engl J Med"},{"key":"3029_CR19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2310234","author":"JS Healey","year":"2023","unstructured":"Healey JS et al (2023) \u201cApixaban for stroke prevention in subclinical atrial fibrillation. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMOA2310234","journal-title":"N Engl J Med"},{"key":"3029_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.067512","author":"WF McIntyre","year":"2023","unstructured":"McIntyre WF et al (2023) \u201cDirect oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET and ARTESiA trials. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067512","journal-title":"Circulation"},{"issue":"17","key":"3029_CR21","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/J.JACC.2010.11.045","volume":"57","author":"CX Wong","year":"2011","unstructured":"Wong CX et al (2011) Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 57(17):1745\u20131751. https:\/\/doi.org\/10.1016\/J.JACC.2010.11.045","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3029_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/PACE.13825","volume":"43","author":"M Zhou","year":"2020","unstructured":"Zhou M, Wang H, Chen J, Zhao L (2020) Epicardial adipose tissue and atrial fibrillation: possible mechanisms, potential therapies, and future directions. Pacing Clin Electrophysiol 43(1):133\u2013145. https:\/\/doi.org\/10.1111\/PACE.13825","journal-title":"Pacing Clin Electrophysiol"},{"issue":"4","key":"3029_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1161\/CIRCEP.109.912055","volume":"3","author":"G Thanassoulis","year":"2010","unstructured":"Thanassoulis G et al (2010) Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol 3(4):345\u2013350. https:\/\/doi.org\/10.1161\/CIRCEP.109.912055","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"3029_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCEP.110.957241","volume":"3","author":"O Batal","year":"2010","unstructured":"Batal O et al (2010) Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythmia Electrophysiol 3(3):230\u2013236. https:\/\/doi.org\/10.1161\/CIRCEP.110.957241","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"3029_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/PRP2.927","author":"SH Huang","year":"2022","unstructured":"Huang SH, Liao CF, Chen ZY, Chao TF, Chen SA, Tsao HM (2022) Distinct atrial remodeling in patients with subclinical atrial fibrillation: lessons from computed tomographic images. Pharmacol Res Perspect. https:\/\/doi.org\/10.1002\/PRP2.927","journal-title":"Pharmacol Res Perspect"},{"issue":"10","key":"3029_CR26","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/J.AMJCARD.2019.08.009","volume":"124","author":"OM Aldaas","year":"2019","unstructured":"Aldaas OM et al (2019) Systematic review and meta-analysis of effect of modest (\u226510%) weight loss in management of overweight and obese patients with atrial fibrillation. Am J Cardiol 124(10):1568. https:\/\/doi.org\/10.1016\/J.AMJCARD.2019.08.009","journal-title":"Am J Cardiol"},{"issue":"6","key":"3029_CR27","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/J.1540-8167.2010.01993.X","volume":"22","author":"SY Shin","year":"2011","unstructured":"Shin SY et al (2011) Total and interatrial epicardial adipose tissues are independently associated with left atrial remodeling in patients with atrial fibrillation. J Cardiovasc Electrophysiol 22(6):647\u2013655. https:\/\/doi.org\/10.1111\/J.1540-8167.2010.01993.X","journal-title":"J Cardiovasc Electrophysiol"},{"key":"3029_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/FCVM.2022.932262","author":"M Conte","year":"2022","unstructured":"Conte M et al (2022) Epicardial adipose tissue and cardiac arrhythmias: focus on atrial fibrillation. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/FCVM.2022.932262","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"3029_CR29","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1253\/CIRCJ.CJ-12-0637","volume":"76","author":"K Nakanishi","year":"2012","unstructured":"Nakanishi K et al (2012) Peri-atrial epicardial adipose tissue is associated with new-onset nonvalvular atrial fibrillation. Circ J 76(12):2748\u20132754. https:\/\/doi.org\/10.1253\/CIRCJ.CJ-12-0637","journal-title":"Circ J"},{"issue":"10","key":"3029_CR30","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/J.AMJCARD.2011.01.027","volume":"107","author":"HM Tsao","year":"2011","unstructured":"Tsao HM et al (2011) Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation and effect of recurrence after ablation. Am J Cardiol 107(10):1498\u20131503. https:\/\/doi.org\/10.1016\/J.AMJCARD.2011.01.027","journal-title":"Am J Cardiol"},{"key":"3029_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-11-15","author":"AJ Nelson","year":"2009","unstructured":"Nelson AJ et al (2009) Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. J Cardiovasc Magn Reson. https:\/\/doi.org\/10.1186\/1532-429X-11-15","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"3029_CR32","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/OBY.2007.591","volume":"15","author":"S Fl\u00fcchter","year":"2007","unstructured":"Fl\u00fcchter S et al (2007) Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity 15(4):870\u2013878. https:\/\/doi.org\/10.1038\/OBY.2007.591","journal-title":"Obesity"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-03029-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-023-03029-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-03029-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T08:08:49Z","timestamp":1711008529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-023-03029-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,21]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["3029"],"URL":"https:\/\/doi.org\/10.1007\/s10554-023-03029-z","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,21]]},"assertion":[{"value":"28 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"JHS is a member of Medtronic advisory boards and has received speaker honoraria and research grants from Medtronic in relation to this work and outside the submitted work. SZD is a part-time employee of Vital Beats and has received speaker fees from Pfizer and advisory honoraria from Bristol-Myers Squibb outside the submitted work. AB reports research grants from The Region of Southern Denmark and The Region of Zealand, and Theravance; speaker honoraria from Bayer, Boehringer Ingelheim, and Bristol-Myers Squibb; and a travel grant from Biotronik, outside the submitted work. LK reports speaker honoraria from Novo, AstraZeneca, Novartis, and Boehringer Ingelheim, outside the submitted work. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}